Search research articles
Contact Us
Filters
Showing results (731-740 of 741) with videos related to
Page
of 75
Sort By:
Physical Review Letters
|
July 9, 2020
Candidate Electromagnetic Counterpart to the Binary Black Hole Merger Gravitational-Wave Event S190521g
M J Graham, K E S Ford, B McKernan, et al.
Nature Immunology
|
December 6, 2023
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8<sup>+</sup> T cells in persons with previous COVID-19
Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Journal of Clinical Microbiology
|
July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
Anton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 17, 2025
Priority research directions for wildfire science: views from a historically fire-prone and an emerging fire-prone country
Kerryn Little, Rayanne Vitali, Claire M Belcher, et al.
The Journal of Allergy and Clinical Immunology
|
July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
David M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
Molecular Genetics and Metabolism
|
April 16, 2015
How strict is galactose restriction in adults with galactosaemia? International practice
S Adam, R Akroyd, S Bernabei, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE
Matthew Greenhawt, Deborah Albright, Sara Anvari, et al.
The New England Journal of Medicine
|
May 10, 2023
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
Matthew Greenhawt, Sayantani B Sindher, Julie Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 28, 2013
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons
Margalida Rotger, Tracy R Glass, Thomas Junier, et al.
Molecular Genetics and Metabolism
|
April 12, 2015
Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach
A Aguiar, K Ahring, M F Almeida, et al.
Page
of 75
Search research articles
Search
Showing results (731-740 of 741) with videos related to
Sort By:
Page
of 75
Physical Review Letters
|
July 9, 2020
Candidate Electromagnetic Counterpart to the Binary Black Hole Merger Gravitational-Wave Event S190521g
M J Graham, K E S Ford, B McKernan, et al.
Nature Immunology
|
December 6, 2023
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8<sup>+</sup> T cells in persons with previous COVID-19
Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Journal of Clinical Microbiology
|
July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
Anton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 17, 2025
Priority research directions for wildfire science: views from a historically fire-prone and an emerging fire-prone country
Kerryn Little, Rayanne Vitali, Claire M Belcher, et al.
The Journal of Allergy and Clinical Immunology
|
July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
David M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
Molecular Genetics and Metabolism
|
April 16, 2015
How strict is galactose restriction in adults with galactosaemia? International practice
S Adam, R Akroyd, S Bernabei, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE
Matthew Greenhawt, Deborah Albright, Sara Anvari, et al.
The New England Journal of Medicine
|
May 10, 2023
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
Matthew Greenhawt, Sayantani B Sindher, Julie Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 28, 2013
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons
Margalida Rotger, Tracy R Glass, Thomas Junier, et al.
Molecular Genetics and Metabolism
|
April 12, 2015
Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach
A Aguiar, K Ahring, M F Almeida, et al.
Page
of 75